Resultados da busca - Tong‐Ming Fu

Refinar Resultados
  1. 1
    Antibody therapies for the prevention and treatment of viral infections

    Antibody therapies for the prevention and treatment of viral infections por Georgina To’a Salazar, Ningyan Zhang, Tong‐Ming Fu, Zhiqiang An

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Natural killer cells in cancer biology and therapy

    Natural killer cells in cancer biology and therapy por Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, Zhi-Ming Shao

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

    Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization por Tong‐Ming Fu, Arthur Friedman, Jeffrey B. Ulmer, M A Liu, John Donnelly

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic Neutralization

    Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic Neutralization por Umesh Katpally, Tong‐Ming Fu, Daniel C. Freed, Danilo R. Casimiro, Thomas J. Smith

    Publicado em 2009
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge

    Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge por Tong‐Ming Fu, Liming Guan, Arthur Friedman, Timothy Schofield, Jeffrey B. Ulmer, Margaret A. Liu, John Donnelly

    Publicado em 1999
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

    Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response por Tong‐Ming Fu, Lei-Jie Dai, Song‐Yang Wu, Yi Xiao, Ding Ma, Yi‐Zhou Jiang, Zhi-Ming Shao

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity

    Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity por Joseph E. Blaney, Eri Nobusawa, Michael A. Brehm, Robert H. Bonneau, Lawrence M. Mylin, Tong‐Ming Fu, Yoshihiro Kawaoka, Satvir S. Tevethia

    Publicado em 1998
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1–Exposed Infants

    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1–Exposed Infants por Kristy M. Bialas, Daniel Westreich, Eduardo Cisneros de la Rosa, Cody S. Nelson, Lawrence M. Kauvar, Tong‐Ming Fu, Sallie R. Permar

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells

    Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells por Xiaohong Cui, Daniel C. Freed, Dai Wang, Ping Qiu, Fengsheng Li, Tong‐Ming Fu, Lawrence M. Kauvar, Michael A. McVoy

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

    Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes por Tong‐Ming Fu, Jeffrey B. Ulmer, Michael J. Caulfield, R. Randall Deck, Arthur Friedman, Su Wang, Xu Liu, John Donnelly, Margaret A. Liu, Hans Wigzell

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine

    Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine por Rebecca T. Emeny, Cosette M. Wheeler, Kathrin U. Jansen, William C. Hunt, Tong‐Ming Fu, Judith F. Smith, Stefani A. MacMullen, Mark T. Esser, Xavier Paliard

    Publicado em 2002
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Putative Immunodominant Human Immunodeficiency Virus-Specific CD8<sup>+</sup>T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype

    Putative Immunodominant Human Immunodeficiency Virus-Specific CD8<sup>+</sup>T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype por Michael R. Betts, Joseph P. Casazza, Brent A. Patterson, Shar L. Waldrop, Wendy L. Trigona, Tong‐Ming Fu, Florian Kern, Louis J. Picker, Richard A. Koup

    Publicado em 2000
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

    Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus por Tong‐Ming Fu, Daniel C. Freed, Melanie Horton, Fan Jiang, Michael Citron, Joseph G. Joyce, Victor M. Garsky, Danilo R. Casimiro, Qinjian Zhao, John W. Shiver, Xiaoping Liang

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Protective CD4<sup>+</sup>and CD8<sup>+</sup>T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

    Protective CD4<sup>+</sup>and CD8<sup>+</sup>T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA por Jeffrey B. Ulmer, Tong‐Ming Fu, R. Randall Deck, Arthur Friedman, Liming Guan, Corrille M. DeWitt, Xu Liu, Su Wang, Margaret A. Liu, John Donnelly, Michael J. Caulfield

    Publicado em 1998
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans

    Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans por Jennifer A. Jenks, Cody S. Nelson, Hunter Roark, Matthew L. Goodwin, Robert F. Pass, David I. Bernstein, Emmanuel B. Walter, Kathryn M. Edwards, Dai Wang, Tong‐Ming Fu, Zhiqiang An, Cliburn Chan, Sallie R. Permar

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination

    Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination por Fengsheng Li, Daniel C. Freed, Aimin Tang, Richard R. Rustandi, Matthew C. Troutman, Amy S. Espeseth, Ningyan Zhang, Zhiqiang An, Michael A. McVoy, Hua Zhu, Sha Ha, Dai Wang, Stuart P. Adler, Tong‐Ming Fu

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques

    A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaque... por Stefania Capone, Annalisa Meola, Bruno Bruni Ercole, Alessandra Vitelli, Monica Pezzanera, Lionello Ruggeri, M E Davies, Rosalba Tafi, Claudia Santini, Alessandra Luzzago, Tong‐Ming Fu, Andrew Bett, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Antonella Folgori

    Publicado em 2006
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Simian Immunodeficiency Virus (SIV)<i>gag</i>DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection

    Simian Immunodeficiency Virus (SIV)<i>gag</i>DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Inf... por Michael A. Egan, William A. Charini, Marcelo J. Kuroda, Jörn E. Schmitz, Paul Rácz, Klara Tenner‐Racz, Kelledy Manson, Michael S. Wyand, Michelle A. Lifton, Christie E. Nickerson, Tong‐Ming Fu, John W. Shiver, Norman L. Letvin

    Publicado em 2000
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors

    Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors por Danilo R. Casimiro, Andrew J. Bett, Tong‐Ming Fu, Mary-Ellen Davies, Aimin Tang, Keith A. Wilson, Minchun Chen, Romnie Long, Troy W. McKelvey, Michael Chastain, Sanjay Gurunathan, Jim Tartaglia, Emilio A. Emini, John W. Shiver

    Publicado em 2004
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects

    Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects por Stuart P. Adler, Nicole Lewis, Anthony Conlon, Mark P. Christiansen, Mohamed Al‐Ibrahim, Richard Rupp, Tong‐Ming Fu, Oliver Bautista, Huaping Tang, Dai Wang, A. Fisher, Timothy D. Culp, Rituparna Das, Karen Beck, Gretchen Tamms, Luwy Musey

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: